CAS 1032900-25-6
:Ceritinib
Description:
Ceritinib is a targeted therapy medication primarily used in the treatment of non-small cell lung cancer (NSCLC) that is characterized by anaplastic lymphoma kinase (ALK) gene rearrangements. It is classified as a kinase inhibitor, specifically designed to inhibit ALK and other related kinases, thereby disrupting cancer cell proliferation and survival. Ceritinib is administered orally and is known for its ability to penetrate the blood-brain barrier, making it effective against central nervous system metastases. The substance has a molecular formula that reflects its complex structure, which includes multiple functional groups that contribute to its pharmacological activity. Common side effects associated with ceritinib include gastrointestinal disturbances, liver enzyme elevations, and fatigue. Due to its mechanism of action, ceritinib is often considered for patients who have progressed on other ALK inhibitors, highlighting its role in personalized cancer therapy. As with any medication, monitoring for adverse effects and drug interactions is essential during treatment.
Formula:C28H36ClN5O3S
InChI:InChI=1S/C28H36ClN5O3S/c1-17(2)37-25-15-21(20-10-12-30-13-11-20)19(5)14-24(25)33-28-31-16-22(29)27(34-28)32-23-8-6-7-9-26(23)38(35,36)18(3)4/h6-9,14-18,20,30H,10-13H2,1-5H3,(H2,31,32,33,34)
InChI key:InChIKey=VERWOWGGCGHDQE-UHFFFAOYSA-N
SMILES:N(C1=C(OC(C)C)C=C(C(C)=C1)C2CCNCC2)C=3N=C(NC4=C(S(C(C)C)(=O)=O)C=CC=C4)C(Cl)=CN3
Synonyms:- 2,4-Pyrimidinediamine, 5-chloro-N<sup>4</sup>-[2-[(1-methylethyl)sulfonyl]phenyl]-N<sup>2</sup>-[5-methyl-2-(1-methylethoxy)-4-(4-piperidinyl)phenyl]-
- 5-Chloro-N4-(2-((1-Methylethyl)Sulfonyl)Phenyl)-N2-(5-Methyl-2-(1-Methylethoxy)-4-(4-Piperidinyl)Phenyl)-2,4-Pyrimidinediamine
- 5-Chloro-N<sup>4</sup>-[2-[(1-methylethyl)sulfonyl]phenyl]-N<sup>2</sup>-[5-methyl-2-(1-methylethoxy)-4-(4-piperidinyl)phenyl]-2,4-pyrimidinediamine
- Ldk 378
- Ldk378
- Zykadia
- Ceritinib
- 2,4-Pyrimidinediamine, 5-chloro-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-N2-[5-methyl-2-(1-methylethoxy)-4-(4-piperidinyl)phenyl]-
Filter by
Purity percentage
0
100
|
0
|
50
|
90
|
95
|
100
Found 13 products.
- Lower prices
- Higher prices
- Lower purities
- Higher purities
- Faster estimated delivery
Ceritinib (Standard)
CAS:Ceritinib (Standard) is a reference standard for research and analysis in studies involving Ceritinib. Ceritinib (LDK378) is an ALK tyrosine kinase inhibitor (IC50=200 pM) with selective, ATP-competitive, and oral activity. Ceritinib also inhibits IGF-1R, InsR, and STK22D (IC50=8/7/23 nM). Ceritinib has antitumor activity.Formula:C28H36ClN5O3SMolecular weight:558.145-Chloro-N2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine
CAS:Controlled ProductApplications 5-Chloro-N2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine, is a Anaplastic lymphoma kinase (ALK) inhibitor.
References Marsilje, T. H., et al.: J. Med. Chem., 56, 5675 (2013);Formula:C28H36ClN5O3SColor and Shape:NeatMolecular weight:558.14Ceritinib
CAS:Ceritinib (LDK378) is an ALK inhibitor with selective, ATP-competitive, and oral activity. Ceritinib has antitumor activity. Cost-effective and quality-assured.Formula:C28H36ClN5O3SPurity:98.52% - 99.77%Color and Shape:SolidMolecular weight:558.14Ceritinib
CAS:ALK receptor tyrosine kinase inhibitor
Formula:C28H36ClN5O3SPurity:Min. 95%Color and Shape:PowderMolecular weight:558.14 g/molCeritinib
CAS:5-Chloro-N2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamineFormula:C28H36ClN5O3SPurity:98%Molecular weight:558.145-chloro-2-N-[5-methyl-4-(piperidin-4-yl)-2-(propan-2-yloxy)phenyl]-4-N-[2-(propane-2-sulfonyl)phenyl]pyrimidine-2,4-diamine
CAS:Formula:C28H36ClN5O3SPurity:98%Color and Shape:SolidMolecular weight:558.1351Ref: IN-DA003ABY
Discontinued product









